Optum buys majority stake in Audax Health Solutions

Optum and Audax Health Solutions, Inc., today announced that Optum has acquired a majority stake in Audax.

Since its founding in 2010, Audax has quickly attracted widespread interest in its technology that enables consumers to better manage their health. Through strategic partnerships with health plans, distribution partners, employers, care providers and condition-management companies, alongside integration with wearables companies like Fitbit, Polar, Withings and BodyMedia, Audax has swiftly gained market share, providing millions of users with its innovative, consumer-centric digital offering. Optum plans to expand Audax's offerings to more broadly support consumers' need for integrated benefit selection, wellness and health care administration.

"Since day one, our vision at Audax has been to positively impact the way consumers manage their health. Today, we took a huge step toward achieving that goal," said Grant Verstandig, CEO and founder of Audax. "Joining with Optum, especially with its unmatched depth of experience and resources, accelerates our momentum, providing the additional reach and scale required to meaningfully advance health care more rapidly."

"Optum and Audax share the common goals of improving health care and making the health system work better, and we believe the combination of our skills and experience serving people across virtually every health care channel can help us reach those goals faster," said David Wichmann, UnitedHealth Group CFO. "The shareholders, customers, leadership and employees of Audax are already making compelling contributions to managing health. We are committed to supporting the ongoing efforts of the Audax team to engage consumers in taking better control of their health."

John Sculley, Audax investor and board member, said, "Optum's investment in Audax is evidence that a new era of consumer engagement and innovation can be the turning point that sets a new trajectory for global health care services."

Audax will operate as a freestanding investment of Optum, serving multiple independent market channels, led by its founder and CEO Grant Verstandig and President and COO David Ko.

Source:

Optum

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ISS experiments reveal new advances in biosensing for cancer diagnostics